Combotope Therapeutics ApS
Private limited companyCVR 44308266København NActive
Combotope Therapeutics ApS is a private limited company, based in København N, active in manufacture of pharmaceutical preparations, founded in 2023. The company made a loss in both 2024 and 2025, most recently DKK 934k. Equity fell to DKK 1.1m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 2.2m to DKK 934k (2024 → 2025).
- Equity fell 21% (2024 → 2025), to DKK 1.1m.
Employees
- 1 more employees than a year earlier: 4 (07/2026) against 3 (07/2025).
Management and owners, last 24 months
- New owners registered: Molior Holding ApS (18/11/2024).
- No longer registered as owner: Molior Holding ApS (17/11/2024).
Registrations, last 24 months
- 17/03/2026: Moved to Ole Maaløes Vej 3, 2200 København N
- 06/11/2025: Share capital changed from 61,300 DKK to 63,300 DKK
- 01/05/2025: Share capital changed from 55,300 DKK to 61,300 DKK
- 18/11/2024: Share capital changed from 51,800 DKK to 55,300 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | −2,060 | −633 | +69.3% |
| Operating profit (EBIT) | −2,803 | −1,198 | +57.3% |
| Profit before tax | −2,801 | −1,198 | +57.2% |
| Net profit | −2,185 | −934 | +57.2% |
| Total assets | 1,381 | 1,089 | −21.1% |
| Equity | 1,355 | 1,070 | −21% |
| Liabilities | 26 | 19 | −28.5% |
| Cash and cash equivalents | 488 | 99 | −79.8% |
| Average number of employees | 1 | 1 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 14/04/2026 | The company | PDF not statedXBRL |
| 2024 | 14/09/2023 – 31/12/2024 | 25/06/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 68,353of 69,742 Better than 2% | No. 32,756of 69,964 Better than 53% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 22of 36 Better than 40% | No. 21of 37 Better than 44% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,188of 16,614 Better than 3% | No. 3,754of 16,661 Better than 77% |
| All companies of type ApS66,508 companies in the comparison | No. 65,311of 66,379 Better than 2% | No. 28,665of 66,505 Better than 57% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Combotope Therapeutics ApS−DKK 633k
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Combotope Therapeutics ApS−DKK 934k
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Combotope Therapeutics ApSDKK 1.1m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Combotope Therapeutics ApS4
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Kolab Holding ApS50%
- Molior Holding ApS33.33%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Søren Nyboe Jakobsen | Director | 14/09/2023 |
| Klas Ola Blixt | Director | 14/09/2023 |
- Founders
- Molior Holding ApS, Laustsen Ventures ApS, Kolab Holding ApS
Signing rule: Selskabet tegnes af én direktør.
Address and production units
1 active production unitsOle Maaløes Vej 3
2200 København N
København Municipality · Postcode 2200
Other companies at the address (8)
- BII Holdings A/SOther financial service activities n.e.c.
- Skape Bio ApSResearch and experimental development on natural sciences and engineering
- Agrobiomics ApSResearch and experimental development on natural sciences and engineering
- Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
- BioColor ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Combotope Therapeutics ApS | Ole Maaløes Vej 3, 2200 København N | 5 | 1029645341 |
Purpose
Selskabets formål er drive erhvervsmæssig virksomhed inden for service, handel og/eller produktion, samt enhver aktivitet, der står i forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
20 registered events20262 changesaccounts 1 · address 1
- AccountsAnnual report for 2025 published
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
20253 changescapital 2 · accounts 1
- CapitalShare capital changed from 61,300 DKK to 63,300 DKK
- AccountsAnnual report for 2024 published
- CapitalShare capital changed from 55,300 DKK to 61,300 DKK
20246 changescapital 2 · ownership 4
- CapitalShare capital changed from 51,800 DKK to 55,300 DKK
- OwnershipMOLIOR HOLDING ApS registered as owner (33.33%)
- OwnershipMOLIOR HOLDING ApS is no longer registered as owner
- CapitalShare capital changed from 45,600 DKK to 51,800 DKK
- OwnershipKolab Holding ApS registered as owner (50%)
- OwnershipKolab Holding ApS is no longer registered as owner
20239 changesaddress 1 · capital 1 · ownership 4 · founded 1 · management 2
- AddressMoved to Diplomvej 381, 2800 Kongens Lyngby
- CapitalShare capital changed from 40,000 DKK to 45,600 DKK
- OwnershipMOLIOR HOLDING ApS registered as owner (33.33%)
- OwnershipMOLIOR HOLDING ApS is no longer registered as owner
- FoundedRegistered as Combotope Therapeutics ApS
- ManagementSøren Nyboe Jakobsen appointed director
- ManagementKlas Ola Blixt appointed director
- OwnershipMOLIOR HOLDING ApS registered as owner (15%)
- OwnershipKolab Holding ApS registered as owner (66.67%)
Related companies
Same industry in København
- H. Lundbeck A/S2,261 employees
- AJ Vaccines A/S499 employees
- Tetra Pharm Technologies ApS39 employees
- Motilitycount ApS29 employees
- Freya Biosciences ApS18 employees
- Zerion Pharma A/S15 employees
Same people in management
- Tetramer Store ApSvia Søren Nyboe Jakobsen
- 10x Genomics Denmark ApSvia Søren Nyboe Jakobsen
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.